Artikel
Traditional vs. new career paths in Biostatistics
Suche in Medline nach
Autoren
-
Anke Huels
- Rollins School of Public Health, Emory University, Atlanta, GA, USA, United States
-
Stefanie Ernst
- Parexel International GmbH, Berlin, Germany
-
Sarah Friedrich
- Department of Medical Statistics, University Medical Center Göttingen, Goettingen, Germany
-
Arthur Allignol
- Merck Healthcare KGaA, Darmstadt, Germany
-
Carsten Schwenke
- SCO:SSiS Statistical Consulting, Berlin, Germany
-
Patrick Cichy
- WESTPHALIA DATALAB GmbH, Muenster, Germany
| Veröffentlicht: | 26. Februar 2021 |
|---|
Gliederung
Text
Academia, industry, self-employment or working in the growing field of data science? What kind of career options do Biostatisticians have and what are the respective advantages and disadvantages? Which steps might be helpful to get there?
These are only some of the questions we would like to discuss with seven invited speakers, who are hand-picked to represent a broad spectrum of career paths in Biostatistics. We invite all early-career statisticians (Bachelor/Master/PhD students and Postdocs), but also more experienced statisticians to join the discussion and ask questions.
With the rapid change of job opportunities, it is often hard to keep track of all the options early-career Biostatisticians have. We want to discuss new as well as traditional job opportunities with our panelists:
In the last couple of years, the German higher education policy has pushed towards the introduction of the tenure-track system and we are proud to have one of the first tenure-track Assistant Professors as one of our panelists. In addition, Anke Huels, who is an Assistant Professor at Emory University (GA, USA) and will lead the panel discussion, will provide some insights about the American version of the tenure-track system which the German tenure-track system is often compared to. Furthermore, we will have panelists from the pharmaceutical industry and from a contract research organization (CRO), who will share with us exciting details of their daily work and how jobs at pharmaceutical companies differ from jobs at CROs. Beside the traditional decision between academia vs. industry, we will also introduce the audience to the life of a self-employed statistical consultant and of a data scientist at a German Data Science Start-up.
The panel discussion will be followed by a get-together, where unanswered questions can be answered.
This session will be organized by the Young Statisticians working group (AG Nachwuchs) of the IBS-DR.
The authors declare that they have no competing interests.
The authors declare that an ethics committee vote is not required.
